Persons with dispensed medicines; background; 2006-2020

Edit table Show description

Persons with dispensed medicines; background; 2006-2020
Sex Age Background and generation Medicine group (ATC) Periods Persons with medicines, relative (%)
Total male and female Total age Total background and generation A Alimentary tract and metabolism 2020 24.24
Total male and female Total age Total background and generation A16 Other aliment.tract/metabol.products 2020 0.02
Total male and female Total age Total background and generation A16A Oth.aliment.tract and metabol.prod. 2020 0.02
Total male and female Total age Total background and generation C02A Antiadren.agents, centrally acting 2020 0.06
Total male and female Total age Total background and generation C02C Antiadren.agents, peripher. acting 2020 0.24
Total male and female Total age Total background and generation J01 Antibacterials for systemic use 2020 16.12
Total male and female Total age Total background and generation J01C Beta-lactam antibact., penicillins 2020 8.92
Total male and female Total age Total background and generation J01D Other beta-lactam antibacterials 2020 0.08
Total male and female Total age Total background and generation J01G Aminoglycoside antibacterials 2020 0.01
Total male and female Total age Total background and generation J01M Quinolone antibacterials 2020 1.59
Total male and female Total age Total background and generation J01R Combinations of antibacterials 2020 0.00
Total male and female Total age Total background and generation J01X Other antibacterials 2020 4.34
Total male and female Total age Total background and generation J04 Antimycobacterials 2020 0.04
Total male and female Total age Total background and generation J05A Direct acting antivirals 2020 0.64
Total male and female Total age Total background and generation J07A Bacterial vaccines 2020 0.85
Total male and female Total age Total background and generation J07C Bacterial and viral vaccines,combi. 2020 0.00
Total male and female Total age Total background and generation M03A Muscle relaxants, peripheral.acting 2020 0.03
Total male and female Total age Total background and generation M03B Muscle relaxants, centrally acting 2020 0.12
Total male and female Total age Total background and generation M03C Muscle relaxants, directly acting 2020 0.00
Total male and female Total age Dutch background A Alimentary tract and metabolism 2020 24.82
Total male and female Total age Dutch background A16 Other aliment.tract/metabol.products 2020 0.02
Total male and female Total age Dutch background A16A Oth.aliment.tract and metabol.prod. 2020 0.02
Total male and female Total age Dutch background C02A Antiadren.agents, centrally acting 2020 0.06
Total male and female Total age Dutch background C02C Antiadren.agents, peripher. acting 2020 0.25
Total male and female Total age Dutch background J01 Antibacterials for systemic use 2020 16.68
Total male and female Total age Dutch background J01C Beta-lactam antibact., penicillins 2020 9.05
Total male and female Total age Dutch background J01D Other beta-lactam antibacterials 2020 0.07
Total male and female Total age Dutch background J01G Aminoglycoside antibacterials 2020 0.01
Total male and female Total age Dutch background J01M Quinolone antibacterials 2020 1.74
Total male and female Total age Dutch background J01R Combinations of antibacterials 2020 0.00
Total male and female Total age Dutch background J01X Other antibacterials 2020 4.69
Total male and female Total age Dutch background J04 Antimycobacterials 2020 0.04
Total male and female Total age Dutch background J05A Direct acting antivirals 2020 0.59
Total male and female Total age Dutch background J07A Bacterial vaccines 2020 0.96
Total male and female Total age Dutch background J07C Bacterial and viral vaccines,combi. 2020 0.00
Total male and female Total age Dutch background M03A Muscle relaxants, peripheral.acting 2020 0.04
Total male and female Total age Dutch background M03B Muscle relaxants, centrally acting 2020 0.13
Total male and female Total age Dutch background M03C Muscle relaxants, directly acting 2020 0.00
Total male and female Total age With migration background A Alimentary tract and metabolism 2020 22.52
Total male and female Total age With migration background A16 Other aliment.tract/metabol.products 2020 0.01
Total male and female Total age With migration background A16A Oth.aliment.tract and metabol.prod. 2020 0.01
Total male and female Total age With migration background C02A Antiadren.agents, centrally acting 2020 0.06
Total male and female Total age With migration background C02C Antiadren.agents, peripher. acting 2020 0.20
Total male and female Total age With migration background J01 Antibacterials for systemic use 2020 14.44
Total male and female Total age With migration background J01C Beta-lactam antibact., penicillins 2020 8.53
Total male and female Total age With migration background J01D Other beta-lactam antibacterials 2020 0.11
Total male and female Total age With migration background J01G Aminoglycoside antibacterials 2020 0.01
Total male and female Total age With migration background J01M Quinolone antibacterials 2020 1.16
Total male and female Total age With migration background J01R Combinations of antibacterials 2020 0.00
Total male and female Total age With migration background J01X Other antibacterials 2020 3.27
Total male and female Total age With migration background J04 Antimycobacterials 2020 0.07
Total male and female Total age With migration background J05A Direct acting antivirals 2020 0.76
Total male and female Total age With migration background J07A Bacterial vaccines 2020 0.51
Total male and female Total age With migration background J07C Bacterial and viral vaccines,combi. 2020 0.00
Total male and female Total age With migration background M03A Muscle relaxants, peripheral.acting 2020 0.01
Total male and female Total age With migration background M03B Muscle relaxants, centrally acting 2020 0.09
Total male and female Total age With migration background M03C Muscle relaxants, directly acting 2020 0.00
Total male and female Total age 1st generation migration background A Alimentary tract and metabolism 2020 26.40
Total male and female Total age 1st generation migration background A16 Other aliment.tract/metabol.products 2020 0.01
Total male and female Total age 1st generation migration background A16A Oth.aliment.tract and metabol.prod. 2020 0.01
Total male and female Total age 1st generation migration background C02A Antiadren.agents, centrally acting 2020 0.07
Total male and female Total age 1st generation migration background C02C Antiadren.agents, peripher. acting 2020 0.26
Total male and female Total age 1st generation migration background J01 Antibacterials for systemic use 2020 14.24
Total male and female Total age 1st generation migration background J01C Beta-lactam antibact., penicillins 2020 8.45
Total male and female Total age 1st generation migration background J01D Other beta-lactam antibacterials 2020 0.09
Total male and female Total age 1st generation migration background J01G Aminoglycoside antibacterials 2020 0.00
Total male and female Total age 1st generation migration background J01M Quinolone antibacterials 2020 1.25
Total male and female Total age 1st generation migration background J01R Combinations of antibacterials 2020 0.00
Total male and female Total age 1st generation migration background J01X Other antibacterials 2020 3.27
Total male and female Total age 1st generation migration background J04 Antimycobacterials 2020 0.09
Total male and female Total age 1st generation migration background J05A Direct acting antivirals 2020 0.95
Total male and female Total age 1st generation migration background J07A Bacterial vaccines 2020 0.49
Total male and female Total age 1st generation migration background J07C Bacterial and viral vaccines,combi. 2020 0.00
Total male and female Total age 1st generation migration background M03A Muscle relaxants, peripheral.acting 2020 0.01
Total male and female Total age 1st generation migration background M03B Muscle relaxants, centrally acting 2020 0.10
Total male and female Total age 1st generation migration background M03C Muscle relaxants, directly acting 2020 0.00
Total male and female Total age 2nd generation migration background A Alimentary tract and metabolism 2020 17.82
Total male and female Total age 2nd generation migration background A16 Other aliment.tract/metabol.products 2020 0.02
Total male and female Total age 2nd generation migration background A16A Oth.aliment.tract and metabol.prod. 2020 0.02
Total male and female Total age 2nd generation migration background C02A Antiadren.agents, centrally acting 2020 0.05
Total male and female Total age 2nd generation migration background C02C Antiadren.agents, peripher. acting 2020 0.13
Total male and female Total age 2nd generation migration background J01 Antibacterials for systemic use 2020 14.68
Total male and female Total age 2nd generation migration background J01C Beta-lactam antibact., penicillins 2020 8.63
Total male and female Total age 2nd generation migration background J01D Other beta-lactam antibacterials 2020 0.13
Total male and female Total age 2nd generation migration background J01G Aminoglycoside antibacterials 2020 0.01
Total male and female Total age 2nd generation migration background J01M Quinolone antibacterials 2020 1.05
Total male and female Total age 2nd generation migration background J01R Combinations of antibacterials 2020 0.00
Total male and female Total age 2nd generation migration background J01X Other antibacterials 2020 3.27
Total male and female Total age 2nd generation migration background J04 Antimycobacterials 2020 0.04
Total male and female Total age 2nd generation migration background J05A Direct acting antivirals 2020 0.54
Total male and female Total age 2nd generation migration background J07A Bacterial vaccines 2020 0.54
Total male and female Total age 2nd generation migration background J07C Bacterial and viral vaccines,combi. 2020 0.00
Total male and female Total age 2nd generation migration background M03A Muscle relaxants, peripheral.acting 2020 0.02
Total male and female Total age 2nd generation migration background M03B Muscle relaxants, centrally acting 2020 0.08
Total male and female Total age 2nd generation migration background M03C Muscle relaxants, directly acting 2020 0.00
Total male and female Total age Western migration background A Alimentary tract and metabolism 2020 19.94
Total male and female Total age Western migration background A16 Other aliment.tract/metabol.products 2020 0.01
Total male and female Total age Western migration background A16A Oth.aliment.tract and metabol.prod. 2020 0.01
Total male and female Total age Western migration background C02A Antiadren.agents, centrally acting 2020 0.06
Total male and female Total age Western migration background C02C Antiadren.agents, peripher. acting 2020 0.21
Source: CBS.
Explanation of symbols

Dataset is not available.


This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
CBS is switching to a new population classification by origin. Greater emphasis will be placed on where a person was born and less on where their parents were born. The term ‘migration background’ will no longer be used in this regard. The main categories western/non-western will be replaced by categories based on continents and a few countries that share a specific migration history with the Netherlands. This classification will gradually been introduced in tables and publications with population by origin.

Data are broken down by medicine group, background, generation, age and sex.

Data available from 2006 to 2020.

Status of the figures:
All figures are definite.

Changes as of 14 December, 2022:
Figures for 2020 have been made final without change and the table has been stopped due to the introduction of the new classification of population by origin.

When will new figures be published?
Not applicable, the table has been stopped. This table will be replaced by the new table 'Persons with dispensed medicines; origin', see chapter 3.

Description topics

Persons with medicines, relative
Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.